Medicare Coverage

    Diabetic Neuropathy Treatment Covered by Medicare

    The NS100 by NeuroDynamics Global is a Medicare-covered, FDA-cleared 20-day neuromodulation therapy for painful diabetic neuropathy. For eligible Medicare beneficiaries, NS100 is reimbursable under established pathways — with no permanent implant and no opioids.

    Am I a Candidate?Contact Us

    Medicare coverage for NS100

    The NS100 by NeuroDynamics Global is reimbursable for eligible Medicare beneficiaries who meet clinical coverage criteria for painful diabetic neuropathy. Coverage is established through standard Medicare pathways used by trained, Medicare-enrolled providers.

    Coverage is patient- and plan-specific. The exact details — including any out-of-pocket cost share — depend on whether you have Original Medicare, a Medicare Advantage plan, and any supplemental coverage. Our team works directly with your provider to verify benefits before the procedure is scheduled.

    We do not collect or store information that would identify a Medicare beneficiary on this page. Verification of benefits is done by your provider's office through standard channels.

    Key facts

    • Medicare reimbursement pathways established
    • FDA-cleared Class II medical device
    • 20-day temporary therapy — no permanent implant
    • Non-opioid, non-pharmacologic
    • Delivered by a Medicare-enrolled provider
    • Benefit verification handled with your provider
    Am I a Candidate?

    Why it matters

    Medicare coverage

    Established reimbursement pathways for eligible Medicare beneficiaries with painful diabetic neuropathy.

    Benefits verification

    Our team helps your treating provider verify your specific coverage and out-of-pocket expectations.

    Provider supervised

    Placed and removed by a trained, Medicare-enrolled physician in a minimally invasive in-office procedure.

    FDA-cleared

    Class II clearance for chronic pain associated with painful diabetic neuropathy.

    What you and your provider will need

    To support a coverage determination, your provider typically documents the diagnosis of painful diabetic neuropathy, the duration of symptoms, prior treatments tried (and the response to each), and clinical rationale for neuromodulation. Our team can supply provider-facing materials that summarize the evidence base and reimbursement workflow.

    If you are a patient, the practical first step is to ask your treating physician whether you are a candidate, and to ask their office to contact NeuroDynamics Global for support with benefits verification.

    Why Medicare coverage matters here

    Diabetic neuropathy is concentrated in adults over 65 — exactly the population Medicare serves. An FDA-cleared, non-opioid, non-implant therapy with established Medicare reimbursement removes one of the largest barriers to access in this category.

    Frequently asked questions

    Ready to learn if NS100 is right for you?

    Connect with our team. We'll help you understand candidacy, coverage, and next steps.

    Am I a Candidate?Learn about NS100